Upgrade to SI Premium - Free Trial

Biogen (BIIB) Stock Edges Higher on Strong Earnings, Sales of New Alzheimer Drug Just $300k

October 20, 2021 9:00 AM
Biogen (NASDAQ: BIIB) stock is up about 1.5% in pre-open Wednesday after the company reported better-than-expected Q3 EPS.BIIB reported Q3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Earnings FDA Guidance Hot Comments Hot Earnings Hot FDA News Hot Guidance

Next Articles